Connecticut Cannabis Industry Sidelines Labelling Rules in Signed Legislation
In May 2026, Connecticut’s cannabis lobby succeeded in removing a mandatory disclosure clause from Public Act 26‑8 before Governor Ned Lamont signed the bill into law. Earlier drafts would have required producers to label any flower treated with ionising radiation—a process the U.S. Food and Drug Administration already mandates for irradiated food—to eliminate microbial contaminants. The final version replaced that specific labeling requirement with generic dispensary signage, a move critics argue prioritises producer convenience over the transparency that a mature, regulated market expects. The change was first reported by the CT Mirror on 22 May.
Iowa Doubles Dispensary Cap to Improve Rural Patient Access
Governor Kim Reynolds signed HF 990 into law, raising the state’s limit on medical cannabis dispensaries from five to ten. The bill passed with strong bipartisan backing—88 votes to 5 in the House and 42 to 5 in the Senate—addressing long‑standing concerns about patient access in Iowa’s rural communities. In addition to expanding the dispensary network, the legislation extends eligibility to out‑of‑state residents who hold a valid certification from an Iowa‑licensed healthcare provider, a provision that could draw patients from neighboring states into Iowa’s regulated framework. Marijuana Moment highlighted the vote tallies and the potential impact on cross‑border patient flow.
Pennsylvania House Passes Hospital Cannabis Access for Terminally Ill Patients
The Pennsylvania House of Representatives approved HB 2254 by a vote of 174 to 27, permitting terminally ill patients to use medical cannabis within hospitals and other healthcare facilities. Under the bill, covered institutions have 180 days to develop safety protocols, and cannabis use is allowed only when it does not interfere with a patient’s treatment or affect others in the facility. The legislation now advances to the state Senate. If enacted, Pennsylvania will join a growing list of states that have carved out specific access provisions for end‑of‑life care, a policy area that consistently garners cross‑party support.
New South Wales Proposes First Australian Exemption for Medical Cannabis Drivers
New South Wales has introduced legislation that would make it the first Australian jurisdiction to allow medical cannabis patients with a valid prescription to drive while carrying measurable THC in their system. The proposal, backed by Premier Chris Minns, applies only to holders of full, unrestricted licences who complete an approved safety programme and remain below a designated THC threshold. Minns argued that zero‑tolerance driving rules are inconsistent with how the law treats patients using other prescription medications. The initiative reflects a broader regulatory challenge: aligning drug‑driving enforcement with an established medical prescribing framework without compromising road safety.
Meta‑Analysis Links Cannabis Medicines to Reduced Tics in Tourette Syndrome
A peer‑reviewed meta‑analysis of eight clinical trials involving 306 adults found that cannabis‑based medicines significantly reduced tics and the urge to tic in patients with Tourette syndrome. Researchers attributed the improvement to modulation of the endocannabinoid system and noted that these compounds may offer better tolerability than conventional antipsychotic agents. The authors cautioned that the evidence base remains limited by small, heterogeneous study sizes, preventing definitive dosing recommendations. The findings are expected to inform discussions at the upcoming DEA rescheduling hearing, scheduled to begin on 29 June.
Watch this week for the Rhode Island Senate and House floor votes on the state’s cannabis licensing bill, which advanced from committee with provisions to restart the retail licensing process and refund previous applicants. The outcome will indicate whether the state can reconcile social‑equity goals with the issuance of new licences.
Source: Here
